Search Results - "Ali, Cherie"
-
1
NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
Published in Clinical cancer research (01-02-2016)“…Aldesleukin, recombinant human IL2, is an effective immunotherapy for metastatic melanoma and renal cancer, with durable responses in approximately 10% of…”
Get full text
Journal Article -
2
NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential
Published in The Journal of pharmacology and experimental therapeutics (01-10-2017)“…The increasing availability of prescription opioid analgesics for the treatment of pain has been paralleled by an epidemic of opioid misuse, diversion, and…”
Get more information
Journal Article -
3
-
4
148 : Modulation of cytokine activity through advanced polymer conjugation
Published in Cytokine (Philadelphia, Pa.) (01-09-2013)“…Cytokines have proven to be effective therapies in multiple indications including those in oncology, inflammation, and immunology. Modification of cytokines…”
Get full text
Journal Article -
5
Abstract 482: Tipping the balance in the tumor microenvironment: An engineered cytokine (NKTR-214) with altered IL2 receptor binding selectivity and improved efficacy
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Introduction Immunotherapy offers the potential for durable responses in a growing list of cancer indications.1 One approach towards stimulating the immune…”
Get full text
Journal Article